Effects of human umbilical cord blood mononuclear cells on respiratory system mechanics in a murine model of neonatal lung injury

References

• Stoll BJ, Hansen NI, Bell EF, Shankaran S, Laptook AR, Walsh MC, et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics. 2010;126:443–456.
   PubMed Web of Science ®Google Scholar
• Jobe AH. The new bronchopulmonary dysplasia. Curr Opin Pediatr. 2011;23:167–172.
   PubMed Web of Science ®Google Scholar
• Bland RD. Neonatal chronic lung disease in the post-surfactant era. Biol Neonate. 2005;88:181–191.
   PubMedGoogle Scholar
• Vom Hove M, Prenzel F, Uhlig HH, Robel-Tillig E. Pulmonary outcome in former preterm, very low birth weight children with bronchopulmonary dysplasia: a case-control follow-up at school age. J Pediatr. 2014;164:40–45e44.
   PubMed Web of Science ®Google Scholar
• Bhandari A, Bhandari V. Pitfalls, problems, and progress in bronchopulmonary dysplasia. Pediatrics. 2009;123:1562–1573.
   PubMed Web of Science ®Google Scholar
• Carraro S, Filippone M, Da Dalt L, Ferraro V, Maretti M, Bressan S, et al. Bronchopulmonary dysplasia: the earliest and perhaps the longest lasting obstructive lung disease in humans. Early Hum Dev. 2013;89(Suppl 3):S3–5.
   Google Scholar
• Smith VC, Zupancic JA, McCormick MC, Croen LA, Greene J, Escobar GJ, et al. Trends in severe bronchopulmonary dysplasia rates between 1994 and 2002. J Pediatr. 2005;146:469–473.
   PubMed Web of Science ®Google Scholar
• Doyle LW. Evaluation of neonatal intensive care for extremely-low-birth-weight infants. Semin Fetal Neonatal Med. 2006;11:139–145.
   PubMed Web of Science ®Google Scholar
• Husain AN, Siddiqui NH, Stocker JT. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol. 1998;29:710–717.
   PubMed Web of Science ®Google Scholar
• Jobe AJ. The new BPD: an arrest of lung development. Pediatr Res. 1999;46:641–643.
   PubMed Web of Science ®Google Scholar
• De Paepe ME, Mao Q, Powell J, Rubin SE, DeKoninck P, Appel N, et al. Growth of pulmonary microvasculature in ventilated preterm infants. Am J Respir Crit Care Med. 2006;173:204–211.
   PubMed Web of Science ®Google Scholar
• De Paepe ME. In: Bhandari V, ed. Pathology of Bronchopulmonary Dysplasia. Switzerland: Springer International Publishing; 2016:149–164.
   Google Scholar
• Berger J, Bhandari V. Animal models of bronchopulmonary dysplasia. I: The term mouse models. Am J Physiol Lung Cell Mol Physiol. 2014;307:L936–947.
   Web of Science ®Google Scholar
• O'Reilly M, Thebaud B. Animal models of bronchopulmonary dysplasia II: the term rat models. Am J Physiol Lung Cell Mol Physiol. 2014;307:L948–958.
   Web of Science ®Google Scholar
• Mao Q, Gundavarapu S, Patel C, Tsai A, Luks FI, De Paepe ME. The Fas system confers protection against alveolar disruption in hyperoxia-exposed newborn mice. Am J Respir Cell Mol Biol. 2008;39:717–729.
   PubMed Web of Science ®Google Scholar
• Weiss DJ. Stem cells, cell therapies, and bioengineering in lung biology and diseases. Comprehensive review of the recent literature 2010–2012. Ann Am Thorac Soc. 2013;10:S45–97.
   Google Scholar
• O'Reilly M, Thebaud B. Cell-based strategies to reconstitute lung function in infants with severe bronchopulmonary dysplasia. Clin Perinatol. 2012;39:703–725.
   PubMed Web of Science ®Google Scholar
• Alphonse RS, Rajabali S, Thebaud B. Lung injury in preterm neonates: the role and therapeutic potential of stem cells. Antioxid Redox Signal. 2012;17:1013–1040.
   PubMed Web of Science ®Google Scholar
• van Haaften T, Byrne R, Bonnet S, Rochefort GY, Akabutu J, Bouchentouf M, et al. Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats. Am J Respir Crit Care Med. 2009;180:1131–1142.
   PubMed Web of Science ®Google Scholar
• Aslam M, Baveja R, Liang OD, Fernandez-Gonzalez A, Lee C, Mitsialis SA, et al. Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease. Am J Respir Crit Care Med. 2009;180:1122–1130.
   PubMed Web of Science ®Google Scholar
• Chang YS, Oh W, Choi SJ, Sung DK, Kim SY, Choi EY, et al. Human umbilical cord blood-derived mesenchymal stem cells attenuate hyperoxia-induced lung injury in neonatal rats. Cell Transplant. 2009;18:869–886.
   PubMed Web of Science ®Google Scholar
• Balasubramaniam V, Ryan SL, Seedorf GJ, Roth EV, Heumann TR, Yoder MC, et al. Bone marrow-derived angiogenic cells restore lung alveolar and vascular structure after neonatal hyperoxia in infant mice. Am J Physiol Lung Cell Mol Physiol. 2010;298:L315–323.
   Google Scholar
• Vosdoganes P, Hodges RJ, Lim R, Westover AJ, Acharya RY, Wallace EM, et al. Human amnion epithelial cells as a treatment for inflammation-induced fetal lung injury in sheep. Am J Obstet Gynecol. 2011;205:156e126–133.
   Web of Science ®Google Scholar
• Hodges RJ, Jenkin G, Hooper SB, Allison B, Lim R, Dickinson H, et al. Human amnion epithelial cells reduce ventilation-induced preterm lung injury in fetal sheep. Am J Obstet Gynecol. 2012;206:448e448–415.
   Web of Science ®Google Scholar
• Mitsialis SA, Kourembanas S. Stem cell-based therapies for the newborn lung and brain: Possibilities and challenges. Semin Perinatol. 2016;40:138–151.
   PubMed Web of Science ®Google Scholar
• Mobius MA, Thebaud B. Stem cells and their mediators - next generation therapy for bronchopulmonary dysplasia. Front Med. 2015;2:50.
   Google Scholar
• Antunes MA, Laffey JG, Pelosi P, Rocco PR. Mesenchymal stem cell trials for pulmonary diseases. J Cell Biochem. 2014.
   Web of Science ®Google Scholar
• Bianco P, Cao X, Frenette PS, Mao JJ, Robey PG, Simmons PJ, et al. The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat Med. 2013;19:35–42.
   PubMed Web of Science ®Google Scholar
• Kogler G, Critser P, Trapp T, Yoder M. Future of cord blood for non-oncology uses. Bone Marrow Transplant. 2009;44:683–697.
   PubMed Web of Science ®Google Scholar
• Chang YS, Choi SJ, Ahn SY, Sung DK, Sung SI, Yoo HS, et al. Timing of umbilical cord blood derived mesenchymal stem cells transplantation determines therapeutic efficacy in the neonatal hyperoxic lung injury. PLoS One. 2013;8:e52419.
   Google Scholar
• Ben-David U, Mayshar Y, Benvenisty N. Large-scale analysis reveals acquisition of lineage-specific chromosomal aberrations in human adult stem cells. Cell Stem Cell. 2011;9:97–102.
   PubMed Web of Science ®Google Scholar
• Grigorian AS, Kruglyakov PV, Taminkina UA, Efimova OA, Pendina AA, Voskresenskaya AV, et al. Alterations of cytological and karyological profile of human mesenchymal stem cells during in vitro culturing. Bull Exp Biol Med. 2010;150:125–130.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang Z, Chi Y, Zhang Q, Xu F, Yang Z, et al. Long-term cultured mesenchymal stem cells frequently develop genomic mutations but do not undergo malignant transformation. Cell Death Dis. 2013;4:e950.
   Google Scholar
• Bara JJ, Richards RG, Alini M, Stoddart MJ Concise review: bone marrow-derived mesenchymal stem cells change phenotype following in vitro culture: implications for basic research and the clinic. Stem Cells. 2014;32:1713–1723.
   PubMed Web of Science ®Google Scholar
• Bentivegna A, Miloso M, Riva G, Foudah D, Butta V, Dalpra L, et al. DNA methylation changes during in vitro propagation of human mesenchymal stem cells: implications for their genomic stability? Stem Cells Int. 2013;2013:192425.
   PubMedGoogle Scholar
• Chang YS, Ahn SY, Yoo HS, Sung SI, Choi SJ, Oh WI, et al. Mesenchymal stem cells for bronchopulmonary dysplasia: phase 1 dose-escalation clinical trial. J Pediatr. 2014;164:966–972.
   Web of Science ®Google Scholar
• Barkholt L, Flory E, Jekerle V, Lucas-Samuel S, Ahnert P, Bisset L, et al. Risk of tumorigenicity in mesenchymal stromal cell-based therapies–bridging scientific observations and regulatory viewpoints. Cytotherapy. 2013;15:753–759.
   PubMed Web of Science ®Google Scholar
• Ballen KK, Verter F, Kurtzberg J Umbilical cord blood donation: public or private? Bone Marrow Transplant. 2015;50:1271–1278.
   PubMed Web of Science ®Google Scholar
• Agadi S, Shetty AK Concise review: prospects of bone marrow mononuclear cells and mesenchymal stem cells for treating status epilepticus and chronic epilepsy. Stem Cells. 2015;33:2093–2103.
   PubMed Web of Science ®Google Scholar
• Hou L, Kim JJ, Woo YJ, Huang NF Stem cell-based therapies to promote angiogenesis in ischemic cardiovascular disease. Am J Physiol Heart Circ Physiol. 2016;310:H455–465.
   Google Scholar
• Bang OY Clinical trials of adult stem cell therapy in patients with ischemic stroke. J Clin Neurol. 2016;12:14–20.
   PubMed Web of Science ®Google Scholar
• Wang ZX, Cao JX, Li D, Zhang XY, Liu JL, Li JL, et al. Clinical efficacy of autologous stem cell transplantation for the treatment of patients with type 2 diabetes mellitus: a meta-analysis. Cytotherapy. 2015;17:956–968.
   PubMed Web of Science ®Google Scholar
• Terai S, Takami T, Yamamoto N, Fujisawa K, Ishikawa T, Urata Y, et al. Status and prospects of liver cirrhosis treatment by using bone marrow-derived cells and mesenchymal cells. Tissue Eng Part B, Rev. 2014;20:206–210.
   PubMed Web of Science ®Google Scholar
• Strauer BE, Brehm M, Zeus T, Kostering M, Hernandez A, Sorg RV, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation. 2002;106:1913–1918.
   PubMed Web of Science ®Google Scholar
• Moniche F, Gonzalez A, Gonzalez-Marcos JR, Carmona M, Pinero P, Espigado I, et al. Intra-arterial bone marrow mononuclear cells in ischemic stroke: a pilot clinical trial. Stroke; A J Cereb Circulation. 2012;43:2242–2244.
   Google Scholar
• Spahr L, Chalandon Y, Terraz S, Kindler V, Rubbia-Brandt L, Frossard JL, et al. Autologous bone marrow mononuclear cell transplantation in patients with decompensated alcoholic liver disease: a randomized controlled trial. PLoS One. 2013;8:e53719.
   Google Scholar
• Abreu SC, Antunes MA, de Castro JC, de Oliveira MV, Bandeira E, Ornellas DS, et al. Bone marrow-derived mononuclear cells vs. mesenchymal stromal cells in experimental allergic asthma. Respir Physiol Neurobiol. 2013;187:190–198.
   PubMed Web of Science ®Google Scholar
• Abreu SC, Antunes MA, Maron-Gutierrez T, Cruz FF, Carmo LG, Ornellas DS, et al. Effects of bone marrow-derived mononuclear cells on airway and lung parenchyma remodeling in a murine model of chronic allergic inflammation. Respir Physiol Neurobiol. 2011;175:153–163.
   PubMed Web of Science ®Google Scholar
• Maron-Gutierrez T, Castiglione RC, Xisto DG, Oliveira MG, Cruz FF, Pecanha R, et al. Bone marrow-derived mononuclear cell therapy attenuates silica-induced lung fibrosis. Eur Respir J. 2011;37:1217–1225.
   PubMed Web of Science ®Google Scholar
• Lopes-Pacheco M, Xisto DG, Ornellas FM, Antunes MA, Abreu SC, Rocco PR, et al. Repeated administration of bone marrow-derived cells prevents disease progression in experimental silicosis. Cell Physiol Biochem. 2013;32:1681–1694.
   PubMed Web of Science ®Google Scholar
• Morales MM, Souza SA, Loivos LP, Lima MA, Szklo A, Vairo L, et al. Pilot safety study of intrabronchial instillation of bone marrow-derived mononuclear cells in patients with silicosis. BMC Pulm Med. 2015;15:66.
   PubMed Web of Science ®Google Scholar
• Rojas M, Parker RE, Thorn N, Corredor C, Iyer SS, Bueno M, et al. Infusion of freshly isolated autologous bone marrow derived mononuclear cells prevents endotoxin-induced lung injury in an ex-vivo perfused swine model. Stem Cell Res Ther. 2013;4:26.
   PubMed Web of Science ®Google Scholar
• Prota LF, Lassance RM, Maron-Gutierrez T, Castiglione RC, Garcia CS, Santana MC, et al. Bone marrow mononuclear cell therapy led to alveolar-capillary membrane repair, improving lung mechanics in endotoxin-induced acute lung injury. Cell Transplant. 2010;19:965–971.
   PubMed Web of Science ®Google Scholar
• Yuhgetsu H, Ohno Y, Funaguchi N, Asai T, Sawada M, Takemura G, et al. Beneficial effects of autologous bone marrow mononuclear cell transplantation against elastase-induced emphysema in rabbits. Exp Lung Res. 2006;32:413–426.
   PubMed Web of Science ®Google Scholar
• Longhini-Dos-Santos N, Barbosa-de-Oliveira VA, Kozma RH, Faria CA, Stessuk T, Frei F, et al. Cell therapy with bone marrow mononuclear cells in elastase-induced pulmonary emphysema. Stem Cell Rev. 2013;9:210–218.
   PubMed Web of Science ®Google Scholar
• Cruz FF, Antunes MA, Abreu SC, Fujisaki LC, Silva JD, Xisto DG, et al. Protective effects of bone marrow mononuclear cell therapy on lung and heart in an elastase-induced emphysema model. Respir Physiol Neurobiol. 2012;182:26–36.
   PubMed Web of Science ®Google Scholar
• Yoshida H, Kitaichi T, Urata M, Kurobe H, Kanbara T, Motoki T, et al. Syngeneic bone marrow mononuclear cells improve pulmonary arterial hypertension through vascular endothelial growth factor upregulation. Ann Thorac Surg. 2009;88:418–424.
   PubMed Web of Science ®Google Scholar
• Luan Y, Zhang ZH, Wei DE, Lu Y, Wang YB Effects of autologous bone marrow mononuclear cells implantation in canine model of pulmonary hypertension. Circ J. 2012;76:977–985.
   Google Scholar
• Ahn SY, Chang YS, Sung DK, Yoo HS, Sung SI, Choi SJ, et al. Cell type-dependent variation in paracrine potency determines therapeutic efficacy against neonatal hyperoxic lung injury. Cytotherapy. 2015;17:1025–1035.
   PubMed Web of Science ®Google Scholar
• Monz D, Tutdibi E, Mildau C, Shen J, Kasoha M, Laschke MW, et al. Human umbilical cord blood mononuclear cells in a double-hit model of bronchopulmonary dysplasia in neonatal mice. PLoS One. 2013;8:e74740.
   Google Scholar
• Fritzell JA, Jr., Mao Q, Gundavarapu S, Pasquariello T, Aliotta JM, Ayala A, et al. Fate and effects of adult bone marrow cells in lungs of normoxic and hyperoxic newborn mice. Am J Respir Cell Mol Biol. 2009;40:575–587.
   PubMed Web of Science ®Google Scholar
• Crapo JD, Barry BE, Foscue HA, Shelburne J Structural and biochemical changes in rat lungs occurring during exposures to lethal and adaptive doses of oxygen. Am Rev Respir Dis. 1980, 122:123–143.
   PubMed Web of Science ®Google Scholar
• Liu L, Mao Q, Chu S, Mounayar M, Abdi R, Fodor W, et al. Intranasal versus intraperitoneal delivery of human umbilical cord tissue-derived cultured mesenchymal stromal cells in a murine model of neonatal lung injury. Am J Pathol. 2014;184:3344–3358.
   PubMed Web of Science ®Google Scholar
• Vanoirbeek JA, Rinaldi M, De Vooght V, Haenen S, Bobic S, Gayan-Ramirez G, et al. Noninvasive and invasive pulmonary function in mouse models of obstructive and restrictive respiratory diseases. Am J Respir Cell Mol Biol. 2010;42:96–104.
   PubMed Web of Science ®Google Scholar
• De Paepe ME, Johnson BD, Papadakis K, Luks FI Lung growth response after tracheal occlusion in fetal rabbits is gestational age-dependent. Am J Respir Cell Mol Biol. 1999;21:65–76.
   PubMed Web of Science ®Google Scholar
• De Paepe ME, Johnson BD, Papadakis K, Sueishi K, Luks FI Temporal pattern of accelerated lung growth after tracheal occlusion in the fetal rabbit. Am J Pathol. 1998;152:179–190.
   PubMed Web of Science ®Google Scholar
• Aherne WA, Dunnill MS In: Aherne WA, Dunnill MS, eds. The Estimation of Whole Organ Volume. London: Edward Arnold Ltd; 1982:10–18.
   Google Scholar
• De Paepe ME, Gundavarapu S, Tantravahi U, Pepperell JR, Haley SA, Luks FI, et al. Fas-ligand-induced apoptosis of respiratory epithelial cells causes disruption of postcanalicular alveolar development. Am J Pathol. 2008;173:42–56.
   PubMed Web of Science ®Google Scholar
• Roura S, Pujal JM, Galvez-Monton C, Bayes-Genis A The role and potential of umbilical cord blood in an era of new therapies: a review. Stem Cell Res Ther. 2015;6:123.
   PubMed Web of Science ®Google Scholar
• Hilgendorff A, Reiss I, Gortner L, Schuler D, Weber K, Lindemann H Impact of airway obstruction on lung function in very preterm infants at term. Pediatr Crit Care Med. A J SocCrit Care Med World Fed Pediatr Intensive Crit Care Soc. 2008;9:629–635.
   Google Scholar
• Vollsaeter M, Roksund OD, Eide GE, Markestad T, Halvorsen T Lung function after preterm birth: development from mid-childhood to adulthood. Thorax. 2013, 68:767–776.
   PubMed Web of Science ®Google Scholar
• O'Reilly M, Sozo F, Harding R Impact of preterm birth and bronchopulmonary dysplasia on the developing lung: long-term consequences for respiratory health. Clin Exp Pharmacol. Physiol. 2013;40:765–773.
   PubMed Web of Science ®Google Scholar
• Abreu SC, Antunes MA, Maron-Gutierrez T, Cruz FF, Ornellas DS, Silva AL, et al. Bone marrow mononuclear cell therapy in experimental allergic asthma: Intratracheal versus intravenous administration. Respir Physiol Neurobiol. 2013;185:615–624.
   PubMed Web of Science ®Google Scholar
• Cruz FF, Borg ZD, Goodwin M, Coffey AL, Wagner DE, Rocco PR, et al. CD11b+ and Sca-1+ cells exert the main beneficial effects of systemically administered bone marrow-derived mononuclear cells in a murine model of mixed Th2/Th17 allergic airway inflammation. Stem Cells Translational Med. 2016;5:488–499.
   PubMed Web of Science ®Google Scholar
• Mayani H, Alvarado-Moreno JA, Flores-Guzman P Biology of human hematopoietic stem and progenitor cells present in circulation. Arch Med Res. 2003;34:476–488.
   PubMed Web of Science ®Google Scholar
• Jaing TH Umbilical cord blood: a trustworthy source of multipotent stem cells for regenerative medicine. Cell Transplant. 2014;23:493–496.
   PubMed Web of Science ®Google Scholar
• Bonfield TL, Koloze M, Lennon DP, Zuchowski B, Yang SE, Caplan AI Human mesenchymal stem cells suppress chronic airway inflammation in the murine ovalbumin asthma model. Am J Physiol Lung Cell Mol Physiol. 2010;299:L760–L770.
   Google Scholar
• Park HK, Cho KS, Park HY, Shin DH, Kim YK, Jung JS, et al. Adipose-derived stromal cells inhibit allergic airway inflammation in mice. Stem Cells Dev. 2010;19:1811–1818.
   PubMed Web of Science ®Google Scholar
• Nemeth K, Keane-Myers A, Brown JM, Metcalfe DD, Gorham JD, Bundoc VG, et al. Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma. Proc Natl Acad Sci U S A. 2010;107:5652–5657.
   PubMed Web of Science ®Google Scholar
• Firinci F, Karaman M, Baran Y, Bagriyanik A, Ayyildiz ZA, Kiray M, et al. Mesenchymal stem cells ameliorate the histopathological changes in a murine model of chronic asthma. Int. Immunopharmacol. 2011;11:1120–1126.
   PubMed Web of Science ®Google Scholar
• Ou-Yang HF, Huang Y, Hu XB, Wu CG Suppression of allergic airway inflammation in a mouse model of asthma by exogenous mesenchymal stem cells. Exp Biol Med (Maywood). 2011;236:1461–1467.
   PubMed Web of Science ®Google Scholar
• Goodwin M, Sueblinvong V, Eisenhauer P, Ziats NP, LeClair L, Poynter ME, et al. Bone marrow-derived mesenchymal stromal cells inhibit Th2-mediated allergic airways inflammation in mice. Stem Cells. 2011;29:1137–1148.
   PubMed Web of Science ®Google Scholar
• Lathrop MJ, Brooks EM, Bonenfant NR, Sokocevic D, Borg ZD, Goodwin M, et al. Mesenchymal stromal cells mediate Aspergillushyphal extract-induced allergic airway inflammation by inhibition of the Th17 signaling pathway. Stem Cells Translational Med. 2014;3:194–205.
   PubMed Web of Science ®Google Scholar
• Cruz FF, Borg ZD, Goodwin M, Sokocevic D, Wagner DE, Coffey A, et al. Systemic administration of human bone marrow-derived mesenchymal stromal cell extracellular vesicles ameliorates aspergillushyphal extract-induced allergic airway inflammation in immunocompetent mice. Stem Cells Translational Med. 2015;4:1302–1316.
   PubMed Web of Science ®Google Scholar
• Kavanagh H, Mahon BP Allogeneic mesenchymal stem cells prevent allergic airway inflammation by inducing murine regulatory T cells. Allergy. 2011;66:523–531.
   PubMed Web of Science ®Google Scholar
• Rogers I, Casper RF Umbilical cord blood stem cells. Best Pract Res Clin Obstet Gynaecol. 2004;18:893–908.
   PubMed Web of Science ®Google Scholar
• Lopes-Pacheco M, Ventura TG, de Oliveira HD, Moncao-Ribeiro LC, Gutfilen B, de Souza SA, et al. Infusion of bone marrow mononuclear cells reduces lung fibrosis but not inflammation in the late stages of murine silicosis. PLoS One. 2014;9:e109982.
   Google Scholar
• Abreu SC, Antunes MA, Mendonca L, Branco VC, de Melo EB, Olsen PC, et al. Effects of bone marrow mononuclear cells from healthy or ovalbumin-induced lung inflammation donors on recipient allergic asthma mice. Stem Cell Res Ther. 2014, 5:108.
   PubMed Web of Science ®Google Scholar
• Silva JD, Paredes BD, Araujo IM, Lopes-Pacheco M, Oliveira MV, Suhett GD, et al. Effects of bone marrow-derived mononuclear cells from healthy or acute respiratory distress syndrome donors on recipient lung-injured mice. Crit Care Med. 2014;42:e510–524.
   Google Scholar
• Lv YT, Zhang Y, Liu M, Qiuwaxi JN, Ashwood P, Cho SC, et al. Transplantation of human cord blood mononuclear cells and umbilical cord-derived mesenchymal stem cells in autism. J Translational Med. 2013;11:196.
   PubMed Web of Science ®Google Scholar
• Wang W, Xu H, Shi Y, Nandedkar S, Zhang H, Gao H, et al. Genetic deletion of apolipoprotein A-I increases airway hyperresponsiveness, inflammation, and collagen deposition in the lung. J Lipid Res. 2010;51:2560–2570.
   PubMed Web of Science ®Google Scholar
• Choi CW, Kim BI, Mason SN, Potts-Kant EN, Brahmajothi MV, Auten RL Intra-amniotic LPS amplifies hyperoxia-induced airway hyperreactivity in neonatal rats. Pediatr Res. 2013;74:11–18.
   PubMed Web of Science ®Google Scholar